Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)

ConditionCancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorH. Lee Moffitt Cancer Center and Research Institute

About this trial

The purpose of the study is to refine, finalize, implement, and evaluate a multi-level intervention aimed at increasing enrollment of Black and Hispanic patients to National Cancer Institute (NCI)-sponsored therapeutic clinic trials at Moffitt Cancer Center.

Eligibility criteria

Qualifiers

Community residents: Community residents may engage with various intervention components deployed in the intervention priority zones.

Community Physicians: may engage with various intervention components deployed in the intervention priority zones if they 1) practice medicine in one of the geographic priority zones.

Cancer Center Physicians: may engage with various intervention components if they 1) practice medicine at Moffitt.

Clinical Research Coordinators (CRC): may engage with various intervention components if they 1) work as a CRC at Moffitt and 2) coordinate/pre-screen patients for at least 1 therapeutic clinical trial at Moffitt.

Disqualifiers

Community residents, Community Physicians, Cancer Center Physicians, Clinical Research Coordinators, and Moffitt patients who do not meet the inclusion criteria.

Trial design

Treatments tested in this trial

  • Continuing Medical Education Events (CME)
  • Trial Connect Portal
  • Clinical Trial Newsletters
  • Implicit Bias Training
  • Recruitment Dashboard
  • Portfolio Profiler
  • Eligibility Calculator
  • Clinical Trial Education Sessions (Community Residents Only)
  • ACT WONDER²S Phone-line/Email (Community Residents and Moffitt Patients)
  • New Patient Information (Moffitt Patients Only)
  • No Intervention

Treatment groups

7,649 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Sponsors and collaborators

H. Lee Moffitt Cancer Center and Research Institute

Lead sponsor

National Cancer Institute (NCI)

Collaborator